Indications
Treatment of glioma.
Composition
- Active substance
- allogeneic glioma tumor cell lysates (inactivated), allogeneic glioma tumor cells (inactivated), autologous glioma tumor cell lysates (inactivated), autologous glioma tumor cells (inactivated)
- International name (INN)
- autologous glioma tumor cell lysates (inactivated);allogeneic glioma tumor cell lysates (inactivated);allogeneic glioma tumor cells (inactivated);autologous glioma tumor cells (inactivated)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sitoiganap
- ATC code
- L01XX
- Therapeutic area
- Glioma, Gliosarcoma